Listed

Amylyx Pharmaceuticals, Inc.

AMLXNasdaqCIK 1658551HealthcareFiscal year ends Dec 31

Reports and events: 89 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Amylyx Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2023-10-1317:20 ET8-K8.01 Other events0001193125-23-256178
2023-10-0416:19 ETSC 13D/AOwnership report, active investor, amended0001193125-23-250741
2023-08-1717:15 ETSC 13D/AOwnership report, active investor, amended0001193125-23-215139
2023-08-1016:14 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041335
2023-08-1016:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-041274
2023-07-2616:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-194655
2023-06-2317:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-173965
2023-06-0908:14 ET8-K5.07 Shareholder vote results0001193125-23-164027
2023-05-1117:04 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021369
2023-05-1116:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-021181
2023-04-2716:06 ETDEF 14AProxy statementPeriod 2023-06-080000950170-23-015261
2023-04-0316:43 ETSC 13D/AOwnership report, active investor, amended0001193125-23-089658
2023-03-2116:51 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-075821
2023-03-1316:54 ET10-KAnnual reportPeriod 2022-12-310000950170-23-007609
2023-03-1316:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-007580
2023-02-1406:30 ET8-K7.01 Regulation FD disclosure0001193125-23-036988
2022-12-0616:06 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-299375
2022-11-1016:12 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-024465
2022-11-1016:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-024448
2022-11-0216:01 ET8-K5.02 Departure or appointment of officers or directors0001193125-22-275812
2022-10-0416:03 ETS-1Registration statement0001193125-22-257577
2022-09-3016:05 ETSC 13D/AOwnership report, active investor, amended0001193125-22-255483
2022-09-3007:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-254838
2022-08-1117:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-218745
2022-08-1116:16 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016883
2022-08-1116:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-016880
2022-07-0517:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-188015
2022-06-1307:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-172425
2022-06-0916:02 ET8-K5.07 Shareholder vote results0001193125-22-171014
2022-06-0307:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-166699
2022-05-1216:26 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-009695
2022-05-1216:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-009674
2022-04-2907:04 ETDEF 14AProxy statementPeriod 2022-06-090001193125-22-130050
2022-03-3114:23 ET10-KAnnual reportPeriod 2021-12-310000950170-22-005157
2022-03-3120:28 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-005093
2022-01-2516:54 ETSC 13DOwnership report, active investor0001193125-22-017123
2022-01-1116:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-22-006731
2022-01-0306:57 ETS-1/ARegistration statement, amended0001193125-22-000260
2021-12-1617:29 ETS-1Registration statement0001193125-21-359405

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 14:43 ET. Listed shows no prices and gives no investment advice.